October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide, radiopharmaceutical and nuclear pharmacy industries in North America — strongly supports legislation recently introduced by Congressman George Holding (R-NC-2) and Seth Moulton (D-MA-6). This legislation, designated H.R.

iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software, demonstrating significant positive results for clinical performance and workflow efficiency. The findings confirmed that the latest artificial intelligence (AI) software solution to support DBT increased improvements in both reader sensitivity (8 percent on average) and specificity (6.9 percent on average). In addition, when reading tomosynthesis cases with the solution, radiologists’ reading times were reduced by more than half (52.7 percent on average).

Carestream is providing a DRX-Transportable System/Lite for the Italian-French Concordia scientific station in Antarctica, located on a 10,500-foot mountain 620 miles from the coast. The station houses 80 scientists during the continent’s three-month summer and about 14 people during the nine-month winter.

Canon Medical Systems USA Inc. launched an all-new program designed to help reduce the leading causes of pain and injury for sonographers from work-related musculoskeletal disorders, which afflict up to 90 percent of clinical sonographers.1 The Healthy Sonographer Program aims to educate sonographers about best practices to prevent positioning themselves in awkward postures – including reaching and twisting – which can result in injuries to the shoulders, neck and wrists and can be a detriment to patient engagement.

The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake City has become the first site in the U.S. to install the nanoScan PET/MRI 3T preclinical in vivo imaging system. This is the 10th installation of the nanoScan positron emission tomography/magnetic resonance imaging (PET/MRI) 3T worldwide.

October 10, 2018 — Mammosphere launched “Where’s My Mammogram?,” a public service campaign to help women obtain copies of prior diagnostic breast images from their physicians. The campaign is intended to empower women to become active participants in their breast health, and to improve clinical outcomes of regular breast cancer screening for women over 40.

DenseBreast-info.org (DB-I) announced the launch of its international expansion for European medical providers. The European expansion of the comprehensive, medically-sourced website for breast density information features an interactive map displaying screening guidelines for selected countries, as well as extensive educational content for healthcare professionals.

The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI) scanner from Siemens Healthineers that brings Siemens’ BioMatrix technology to the 1.5T market. This technology addresses patient anatomical and physiological differences, as well as differences in how users set up and conduct MRI exams, to increase productivity and decrease rescans for improved efficiency and patient satisfaction.

A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness of radiation therapy versus surgery in treating an increasingly diagnosed head and neck cancer. Given these results, investigators suggest quality-of-life factors should help inform a treatment decision between the two therapies.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now